Notice Type
Departmental
Notice Title

Corrigendum—Full Exemption of Certain COVID-19 Point-of-care Tests Under the COVID-19 Public Health Response (Point-of-care Tests) Order 2021

Pursuant to Clause 9 of the COVID-19 Public Health Response (Point-of-care Tests) Order 2021 (“Order”), I, Dr Diana Sarfati, Director-General of Health, exempt the following point-of-care rapid antigen test from all prohibitions under clause 7 of the Order.

Product name(s): AllTest SARS-CoV-2 Antigen Rapid Test

Manufacturer (country): Hangzhou AllTest Biotech Co., Ltd. (China)

Sample type(s): Nasal swab

Product configuration: Professional or Self-test of any package size

Product name(s): JusChek SARS-CoV-2 Antigen Rapid Test

Manufacturer (country): Hangzhou AllTest Biotech Co., Ltd. (China)

Sample type(s): Nasal swab

Product configuration: Professional or Self-test of any package size

Product name(s): BeRight SARS-CoV-2 Antigen Rapid Test

Manufacturer (country): Hangzhou AllTest Biotech Co., Ltd. (China)

Sample type(s): Nasal swab

Product configuration: Professional or Self-test of any package size

Product name(s): Gold Standard Diagnostics (GSD) SARS-CoV-2 Antigen Rapid Test

Manufacturer (country): Hangzhou AllTest Biotech Co., Ltd. (China)

Sample type(s): Nasal swab

Product configuration: Self-test of any package size


Dated at Wellington this 8th day of September 2022.

Dr DIANA SARFATI, Director-General of Health.

Note: This notice replaces the notice published in the New Zealand Gazette, 9 September 2022, Notice No. 2022-go3738.